Provided by Tiger Trade Technology Pte. Ltd.

Bio-Techne

57.92
+0.05000.09%
Post-market: 56.77-1.1500-1.99%18:37 EST
Volume:2.18M
Turnover:124.63M
Market Cap:9.02B
PE:111.54
High:58.15
Open:57.58
Low:55.90
Close:57.87
52wk High:72.16
52wk Low:46.01
Shares:155.81M
Float Shares:154.93M
Volume Ratio:0.82
T/O Rate:1.41%
Dividend:0.32
Dividend Rate:0.55%
EPS(TTM):0.5193
EPS(LYR):0.4600
ROE:3.97%
ROA:6.52%
PB:4.49
PE(LYR):125.91

Loading ...

U.S. RESEARCH ROUNDUP-Amazon, Estée Lauder, Ralph Lauren

Reuters
·
Feb 06

Table: G-TECH Optoelectronics Jan Rev NT$273.5M Vs NT$179.0M

Dow Jones
·
Feb 06

Bio-Techne Corp. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Feb 06

Bio-Techne Is Maintained at In-Line by Evercore ISI Group

Dow Jones
·
Feb 05

Stifel Nicolaus Adjusts Bio-Techne PT to $65 From $60, Maintains Hold Rating

MT Newswires Live
·
Feb 05

Wells Fargo Adjusts Bio-Techne PT to $76 From $70, Maintains Overweight Rating

MT Newswires Live
·
Feb 05

Evercore ISI Adjusts Price Target on Bio-Techne to $68 From $62, Maintains In Line Rating

MT Newswires Live
·
Feb 05

Analysts Offer Insights on Healthcare Companies: Bio-Techne (TECH) and Aytu BioScience (AYTU)

TIPRANKS
·
Feb 05

U.S. RESEARCH ROUNDUP-Alphabet, Corteva, Varonis Systems

Reuters
·
Feb 05

Bio-Techne Earnings Call Balances Headwinds With Margin Gains

TIPRANKS
·
Feb 05

Analysts Offer Insights on Healthcare Companies: Neuren Pharmaceuticals Limited (OtherNURPF) and Bio-Techne (TECH)

TIPRANKS
·
Feb 05

Bio-Techne Corp. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Feb 05

Bio-Techne: Near-Term Resilience and Margin Expansion Support Accelerating Growth and Buy Rating Into 2027

TIPRANKS
·
Feb 05

Bio-Techne price target raised to $80 from $70 at Citi

TIPRANKS
·
Feb 05

Stock Track | Bio-Techne Soars 5.14% in Pre-Market on Strong Q2 Earnings Beat and China/APAC Growth

Stock Track
·
Feb 04

Bio-Techne Shares up 2.54% After Q2 Results Beat Estimates

THOMSON REUTERS
·
Feb 04

BUZZ-U.S. STOCKS ON THE MOVE-Bio-Techne, AbbVie, Johnson Controls

Reuters
·
Feb 04

Bio-Techne Exec Says Modest Decline in Co's US Academic Business Was Partially Offset by Stable Growth in Europe - Conf Call

THOMSON REUTERS
·
Feb 04

Stock Track | Bio-Techne Soars 5.04% in Pre-Market on Better-Than-Expected Quarterly Results

Stock Track
·
Feb 04

Bio-Techne Declares Quarterly Dividend of $0.08 a Share, Payable Feb. 27 to Shareholders of Record on Feb. 16

MT Newswires Live
·
Feb 04